Study to Evaluate the Safety and Tolerability of Ferric Citrate in Children With Hyperphosphatemia Related to Chronic Kidney Disease

Summary

This study will be conducted to assess the safety and tolerability of ferric citrate in pediatric participants with hyperphosphatemia related to chronic kidney disease (CKD).

Timeline

Start

2022-06-16

Primary completion

2026-12

Completion

2027-10

Outcome

Outcome not reported

Stopped (Business): “Sponsor decision”

Drugs

Indications